ES2636976T3 - Genes de Plasmodium malariae y Plasmodium ovale y usos de los mismos - Google Patents
Genes de Plasmodium malariae y Plasmodium ovale y usos de los mismos Download PDFInfo
- Publication number
- ES2636976T3 ES2636976T3 ES09717602T ES09717602T ES2636976T3 ES 2636976 T3 ES2636976 T3 ES 2636976T3 ES 09717602 T ES09717602 T ES 09717602T ES 09717602 T ES09717602 T ES 09717602T ES 2636976 T3 ES2636976 T3 ES 2636976T3
- Authority
- ES
- Spain
- Prior art keywords
- antibody
- antigen
- malariae
- ovale
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000223821 Plasmodium malariae Species 0.000 title abstract 5
- 241001505293 Plasmodium ovale Species 0.000 title abstract 5
- 229940118768 plasmodium malariae Drugs 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 10
- 102000036639 antigens Human genes 0.000 abstract 10
- 108091007433 antigens Proteins 0.000 abstract 10
- 241000223960 Plasmodium falciparum Species 0.000 abstract 4
- 206010035501 Plasmodium malariae infection Diseases 0.000 abstract 4
- 206010035502 Plasmodium ovale infection Diseases 0.000 abstract 4
- 241000223810 Plasmodium vivax Species 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 150000001875 compounds Chemical group 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Un método para detectar anticuerpos contra P. malariae, P. ovale, P. vivax y P. falciparum en una muestra de ensayo que se sospecha que contiene al menos uno de dichos anticuerpos que comprende las etapas de: (a) poner en contacto dicha muestra de ensayo con 1) un antígeno de polipéptido MSP1-p19 de P. malariae que consiste en la secuencia de aminoácidos de SEQ ID NO: 47, 2) un antígeno de oolipéptido MSP1-p19 de P. ovale que consiste en la secuencia de aminoácidos de SEQ ID NO: 48, 3) un antígeno de polipéptido MSP1-p19 de P. vivax que consiste en la secuencia de aminoácidos de la SEQ ID NO: 45 y 4) un antígeno de polipéptido MSP1-p19 de P. falciparum que consiste en la secuencia de aminoácidos de SEQ ID NO: 46, en donde que los antígenos están unidos a una fase sólida, durante un tiempo y bajo condiciones suficientes para permitir la formación de complejos de anticuerpo/antígeno de P. malariae, complejos de anticuerpo/antígeno de P. ovale, complejos de anticuerpo/antígeno de P. vivax y complejos de anticuerpo/antígeno de P. falciparum; (b) añadir un producto conjugado a los complejos de anticuerpo/antígeno resultantes durante un tiempo y bajo condiciones suficientes para permitir que cada producto conjugado se una al anticuerpo unido, en donde dicho producto conjugado comprende un anti-anticuerpo humano anclado a un compuesto generador de señal capaz de generar un complejo detectable señal; y (c) detectar la presencia de anticuerpo contra el anticuerpo de P. malariae, P. ovale, P. vivax y P. falciparum que puede estar presente en dicha muestra de ensayo detectando la presencia de dicha señal generada por dicho compuesto generador de señal.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6837508P | 2008-03-06 | 2008-03-06 | |
US12/143,137 US8030471B2 (en) | 2008-03-06 | 2008-06-20 | Plasmodium malariae and Plasmodium ovale genes and uses thereof |
US12/397,558 US8268981B2 (en) | 2008-03-06 | 2009-03-04 | Plasmodium malariae and plasmodium ovale genes and uses thereof |
PCT/US2009/036098 WO2009111599A2 (en) | 2008-03-06 | 2009-03-05 | Plasmodium malariae and plasmodium ovale genes and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2636976T3 true ES2636976T3 (es) | 2017-10-10 |
Family
ID=41056643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09717602T Active ES2636976T3 (es) | 2008-03-06 | 2009-03-05 | Genes de Plasmodium malariae y Plasmodium ovale y usos de los mismos |
Country Status (4)
Country | Link |
---|---|
US (1) | US8268981B2 (es) |
EP (1) | EP2393824B1 (es) |
ES (1) | ES2636976T3 (es) |
WO (1) | WO2009111599A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8030471B2 (en) * | 2008-03-06 | 2011-10-04 | Abbott Laboratories | Plasmodium malariae and Plasmodium ovale genes and uses thereof |
EP3667322A1 (en) | 2018-12-14 | 2020-06-17 | Euroimmun Medizinische Labordiagnostika AG | Serological detection of plasmodium antibodies |
BR102020000922A2 (pt) * | 2019-01-24 | 2021-11-30 | Euroimmun Medizinische Labordiagnostika Ag | Detecção sorológica de anticorpos de plasmodium |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1982001011A1 (en) | 1980-09-24 | 1982-04-01 | Corp Cetus | Diagnostic method and probe |
DE3381518D1 (de) | 1982-01-22 | 1990-06-07 | Cetus Corp | Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel. |
US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
US4683194A (en) | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5107065A (en) | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
CA1338457C (en) | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
US5006309A (en) | 1988-04-22 | 1991-04-09 | Abbott Laboratories | Immunoassay device with liquid transfer between wells by washing |
US5089424A (en) | 1988-06-14 | 1992-02-18 | Abbott Laboratories | Method and apparatus for heterogeneous chemiluminescence assay |
US5063081A (en) | 1988-11-14 | 1991-11-05 | I-Stat Corporation | Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor |
US5231020A (en) | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
US5912120A (en) | 1992-04-09 | 1999-06-15 | The United States Of America As Represented By The Department Of Health And Human Services, | Cloning, expression and diagnosis of human cytochrome P450 2C19: the principal determinant of s-mephenytoin metabolism |
WO1995024488A1 (en) | 1994-03-09 | 1995-09-14 | Abbott Laboratories | Transgenic animals producing oligosaccharides and glycoconjugates |
US5750176A (en) | 1994-03-09 | 1998-05-12 | Abbott Laboratories | Transgenic non-human mammal milk comprising 2'-fucosyl-lactose |
US5705330A (en) | 1995-04-14 | 1998-01-06 | Abbott Laboratories | Chemiluminescent immunoassay for antibody detection |
US5856194A (en) | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
US5795784A (en) | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
US6395472B1 (en) | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
AU1600401A (en) | 1999-11-12 | 2001-06-06 | Chinese University Of Hong Kong, The | Malaria vaccine |
WO2001036587A2 (en) | 1999-11-15 | 2001-05-25 | Humanbio Co., Ltd. | Gene for encoding merozoite surface protein of plasmodium vivax and use thereof |
US7419821B2 (en) | 2002-03-05 | 2008-09-02 | I-Stat Corporation | Apparatus and methods for analyte measurement and immunoassay |
US20040018577A1 (en) | 2002-07-29 | 2004-01-29 | Emerson Campbell John Lewis | Multiple hybrid immunoassay |
US7723099B2 (en) | 2003-09-10 | 2010-05-25 | Abbott Point Of Care Inc. | Immunoassay device with immuno-reference electrode |
US7682833B2 (en) | 2003-09-10 | 2010-03-23 | Abbott Point Of Care Inc. | Immunoassay device with improved sample closure |
EP1529536A1 (en) | 2003-11-05 | 2005-05-11 | Institut Pasteur | Immunogenic composition having improved immunostimulation capacity |
US20080213318A1 (en) | 2005-07-05 | 2008-09-04 | Hawaii Biotech, Inc. | Malaria MSP-1 C-terminal enhanced subunit vaccine |
-
2009
- 2009-03-04 US US12/397,558 patent/US8268981B2/en active Active
- 2009-03-05 ES ES09717602T patent/ES2636976T3/es active Active
- 2009-03-05 EP EP09717602.8A patent/EP2393824B1/en active Active
- 2009-03-05 WO PCT/US2009/036098 patent/WO2009111599A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US8268981B2 (en) | 2012-09-18 |
EP2393824B1 (en) | 2017-05-31 |
WO2009111599A2 (en) | 2009-09-11 |
US20090232797A1 (en) | 2009-09-17 |
WO2009111599A3 (en) | 2012-02-02 |
EP2393824A2 (en) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Souto et al. | SPR analysis of the interaction between a recombinant protein of unknown function in Leishmania infantum immobilised on dendrimers and antibodies of the visceral leishmaniasis: A potential use in immunodiagnosis | |
Haun et al. | Probing intracellular biomarkers and mediators of cell activation using nanosensors and bioorthogonal chemistry | |
Blanco-Canosa et al. | Recent progress in the bioconjugation of quantum dots | |
CA2817202C (en) | Hydroxycholesterol immunoassay | |
WO2008027942A3 (en) | Combination hepatitis c virus antigen and antibody detection method | |
CO6331370A2 (es) | Anticuerpos contra el receptor de productos finales de glicosilacion avanzada (rage) y usos de los mismos | |
Kim et al. | Highly sensitive detection of cardiac troponin I in human serum using gold nanoparticle-based enhanced sandwich immunoassay | |
Tria et al. | Microfabricated biosensor for the simultaneous amperometric and luminescence detection and monitoring of Ochratoxin A | |
Banala et al. | No washing, less waiting: engineering biomolecular reporters for single-step antibody detection in solution | |
WO2008103319A3 (en) | Compounds and methods for use in detecting gabapentin | |
Prieto-Simón et al. | High-sensitive flow-based kinetic exclusion assay for okadaic acid assessment in shellfish samples | |
KR20120003903A (ko) | 생물학적 시료중의 물질을 검출하는 방법 | |
ES2636976T3 (es) | Genes de Plasmodium malariae y Plasmodium ovale y usos de los mismos | |
JP5647599B2 (ja) | 生物学的試料中の物質を検出する方法 | |
RU2014146707A (ru) | Антитела против тофацитиниба и их применение для лекарственного мониторинга | |
KR20080054963A (ko) | 앱타머를 포함하는 폴리다이아세틸렌 센서칩 및 그제조방법 | |
Batra et al. | Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen | |
JPWO2013018836A1 (ja) | 生物学的試料中の物質を検出する工程において、非特異的結合を抑制する方法、当該方法に使用するための剤 | |
KR100848105B1 (ko) | 단백질을 포함하는 폴리다이아세틸렌 센서칩 및 그제조방법 | |
Ruwona et al. | Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes | |
Lee et al. | One-step immunoassay for the detection of food-poisoning related bacteria using a switching peptide | |
AR086924A1 (es) | Anticuerpos anti-receptor de epo humano y los metodos para su utilizacion | |
Stipić et al. | Antibody-based donor–acceptor spatial reconfiguration in decorated lanthanide-doped nanoparticle colloids for the quantification of okadaic acid biotoxin | |
Jiménez-Sánchez et al. | Improving bioassay sensitivity through immobilization of bio-probes onto reactive micelles | |
RU2009124225A (ru) | Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis |